Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Crystal L Mackall

Showing results (121-130 of 232) with videos related to

Pageof 24
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|April 4, 2007
Potential role for IL-7 in Fas-mediated T cell apoptosis during HIV infectionCaroline Fluur, Angelo De Milito, Terry J Fry, et al.
Nature Medicine|April 18, 2018
Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M<sup>+</sup> diffuse midline gliomasChristopher W Mount, Robbie G Majzner, Shree Sundaresh, et al.
Molecular Therapy. Oncology|March 4, 2025
Development of multivalent CAR T cells as dual immunotherapy and conditioning agentsQuenton Rashawn Bubb, Mohammad Balood, Gabe Eduardo Seir, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 27, 2018
Systematic Evaluation of Neurotoxicity in Children and Young Adults Undergoing CD22 Chimeric Antigen Receptor T-Cell TherapyHaneen Shalabi, Pamela L Wolters, Staci Martin, et al.
Nature Immunology|January 13, 2009
Interleukin 7 signaling in dendritic cells regulates the homeostatic proliferation and niche size of CD4+ T cellsMartin Guimond, Rachelle G Veenstra, David J Grindler, et al.
Cancer Research|September 22, 2020
PET Reporter Gene Imaging and Ganciclovir-Mediated Ablation of Chimeric Antigen Receptor T Cells in Solid TumorsSurya Murty, Louai Labanieh, Tara Murty, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 30, 2016
Adjuvant Immunotherapy to Improve Outcome in High-Risk Pediatric SarcomasMelinda S Merchant, Donna Bernstein, Martha Amoako, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 16, 2006
IL-7 administration to humans leads to expansion of CD8+ and CD4+ cells but a relative decrease of CD4+ T-regulatory cellsSteven A Rosenberg, Claude Sportès, Mojgan Ahmadzadeh, et al.
Journal for Immunotherapy of Cancer|December 2, 2025
Enabling access to genetically modified cell therapies through flexible approaches to manufacturing and cost recoveryMark D Stewart, Christopher R Cabanski, Jeff D Allen, et al.
Cell|May 16, 2026
Cell-autonomous control of CAR signaling and receptor shedding via ADAM17-mediated proteolysisJeremy R Bjelajac, Adrià Cañellas-Socias, Preeti Nehra, et al.
Pageof 24

Showing results (121-130 of 232) with videos related to

Sort By:
Pageof 24
Journal of Immunology (Baltimore, Md. : 1950)|April 4, 2007
Potential role for IL-7 in Fas-mediated T cell apoptosis during HIV infectionCaroline Fluur, Angelo De Milito, Terry J Fry, et al.
Nature Medicine|April 18, 2018
Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M<sup>+</sup> diffuse midline gliomasChristopher W Mount, Robbie G Majzner, Shree Sundaresh, et al.
Molecular Therapy. Oncology|March 4, 2025
Development of multivalent CAR T cells as dual immunotherapy and conditioning agentsQuenton Rashawn Bubb, Mohammad Balood, Gabe Eduardo Seir, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 27, 2018
Systematic Evaluation of Neurotoxicity in Children and Young Adults Undergoing CD22 Chimeric Antigen Receptor T-Cell TherapyHaneen Shalabi, Pamela L Wolters, Staci Martin, et al.
Nature Immunology|January 13, 2009
Interleukin 7 signaling in dendritic cells regulates the homeostatic proliferation and niche size of CD4+ T cellsMartin Guimond, Rachelle G Veenstra, David J Grindler, et al.
Cancer Research|September 22, 2020
PET Reporter Gene Imaging and Ganciclovir-Mediated Ablation of Chimeric Antigen Receptor T Cells in Solid TumorsSurya Murty, Louai Labanieh, Tara Murty, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 30, 2016
Adjuvant Immunotherapy to Improve Outcome in High-Risk Pediatric SarcomasMelinda S Merchant, Donna Bernstein, Martha Amoako, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 16, 2006
IL-7 administration to humans leads to expansion of CD8+ and CD4+ cells but a relative decrease of CD4+ T-regulatory cellsSteven A Rosenberg, Claude Sportès, Mojgan Ahmadzadeh, et al.
Journal for Immunotherapy of Cancer|December 2, 2025
Enabling access to genetically modified cell therapies through flexible approaches to manufacturing and cost recoveryMark D Stewart, Christopher R Cabanski, Jeff D Allen, et al.
Cell|May 16, 2026
Cell-autonomous control of CAR signaling and receptor shedding via ADAM17-mediated proteolysisJeremy R Bjelajac, Adrià Cañellas-Socias, Preeti Nehra, et al.
Pageof 24